ANGO R&D Expenses
Angiodynamics Inc · R&D Expenses
ANGO R&D Expenses
Latest reported$31.01Mperiod ending
ANGO TTM R&D Expenses ($4.07M → $31.01M)
TTM R&D Expenses
High-resolution chart · PNG
ANGO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 31,009,000 | |
| 29,447,000 | |
| 27,859,000 | |
| 27,688,000 | |
| 26,354,000 | |
| 26,222,000 | |
| 26,356,000 | |
| 27,632,000 | |
| 29,856,000 | |
| 31,512,000 | |
| 32,648,000 | |
| 31,311,000 | |
| 29,491,000 | |
| 29,883,000 | |
| 29,889,000 | |
| 30,317,000 | |
| 31,678,000 | |
| 30,739,000 | |
| 31,977,000 | |
| 33,262,000 | |
| 34,775,000 | |
| 36,390,000 | |
| 34,518,000 | |
| 34,348,000 | |
| 32,400,000 | |
| 29,683,000 | |
| 29,651,000 | |
| 28,466,000 | |
| 28,065,000 | |
| 29,435,000 | |
| 28,689,000 | |
| 27,936,000 | |
| 26,680,000 | |
| 25,459,000 | |
| 25,701,000 | |
| 25,195,000 | |
| 25,001,000 | |
| 25,269,000 | |
| 25,510,000 | |
| 25,367,000 | |
| 25,633,000 | |
| 25,126,000 | |
| 25,478,000 | |
| 26,525,000 | |
| 26,415,000 | |
| 26,931,000 | |
| 26,395,000 | |
| 26,585,000 | |
| 27,519,000 | |
| 27,510,000 | |
| 27,195,000 | |
| 25,943,000 | |
| 25,954,000 | |
| 26,319,000 | |
| 25,103,000 | |
| 23,884,000 | |
| 21,995,000 | |
| 20,512,000 | |
| 20,839,000 | |
| 21,587,000 | |
| 21,721,000 | |
| 21,372,000 | |
| 21,197,000 | |
| 20,164,000 | |
| 19,668,000 | |
| 19,275,000 | |
| 18,736,000 | |
| 19,139,000 | |
| 18,801,000 | |
| 17,914,000 | |
| 17,143,000 | |
| 16,406,000 | |
| 15,675,000 | |
| 14,424,000 | |
| 13,403,000 | |
| 23,696,000 | |
| 21,639,000 | |
| 20,555,000 | |
| 18,871,000 | |
| 6,069,000 | |
| 5,977,000 | |
| 5,869,000 | |
| 5,804,000 | |
| 5,384,000 | |
| 4,961,000 | |
| 4,570,000 | |
| 4,230,000 | |
| 4,070,000 | |
| 3,688,000 | |
| 2,560,000 |